Baxter's Bloomington facility to manufacture Moderna's COVID-19 vaccine

Baxter International Inc. recently announced a deal with Moderna to produce 60-90 million doses of COVID-19 vaccines by year’s end. Baxter BioPharma Solutions will provide fill/finish sterile manufacturing services and supply packaging from its Bloomington facilities. Catalent is also producing Moderna’s COVID-19 vaccine at its Bloomington facilities.
Read more...

;